Nasal spray prevents Covid-19 spread
Israeli biotech Nasus has developed the Taffix anti-viral nasal spray. It creates a thin gel over the nasal mucosa, blocking viruses for 4-5 hours. In recent tests, Taffix reduced Covid-19 infections from 10% down to 2.4%. Taffix is marketed in Europe and available at SuperPharm in Israel.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink